Immunonutrition improves the prognosis of patients with cancer

doi:10.3969/j.issn.1006-7795.2020.06.027

Abstract

Abstract: At present, nutritional support is no longer an adjuvant treatment for cancer, but a first-line treatment that can improve the prognosis of patients and prolong their lifespan. Many studies believe that nutrients not only provide patients with the essential energy, but some nutritional preparations can inhibit tumor cells and prevent carcinogenesis by regulating immunity. However, the mechanism is not entirely clear. This review closely followed the theme of “tumor immunity” and list some examples of successful nutritional treatments, such as diet patterns, amino acids, omega-3 polyunsaturated fatty acids, trace elements, vitamins, dietary fiber, and probiotics, etc. This review also analyzed that nutrients affect the growth, differentiation, autophagy, apoptosis of tumors by regulating the body's immunity. The term “immune nutrition” allows us to consider the concept of a dietary immune index for better designing and optimizing the combination and efficacy of dietary immune modulators, and thus to provide a new direction to explore the new dietary components and mechanisms of immune regulation.

Key words: nutrition, diet, tumor immunity, prognosis, cancer risk, dietary inflammation index

CLC Number:

Wang Xin, Zhang Junxuan, Gao Jian, Shi Hanping. Immunonutrition improves the prognosis of patients with cancer[J]. Journal of Capital Medical University, 2020, 41(6): 1019-1024.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.06.027

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I6/1019

References

[1] Mittal D, Gubin M M, Schreiber R D, et al. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape[J]. Curr Opin Immunol, 2014, 27:16-25.
[2] Krysko D V, Garg A D, Kaczmarek A, et al. Immunogenic cell death and DAMPs in cancer therapy[J]. Nat Rev Cancer, 2012, 12(12):860-875.
[3] Galluzzi L, Buque A, Kepp O, et al. Immunological effects of conventional chemotherapy and targeted anticancer agents[J]. Cancer Cell,2015, 28(6):690-714.
[4] Sharma P, Allison J P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential[J]. Cell, 2015, 161(2):205-214.
[5] Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer[J]. Nat Immunol, 2017, 18:843-850.
[6] van Niekerk G, Loos B, Nell T, et al. Autophagy—a free meal in sickness-associated anorexia[J]. Autophagy, 2016, 12(4):727-734.
[7] Wei M, Brandhorst S, Shelehchi M, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease[J]. Sci Transl Med, 2017, 9(377): eai8700
[8] Puchalska P, Crawford P A. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics[J]. Cell Metab, 2017, 25(2):262-284.
[9] Wang A, Huen S C, Luan H H, et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation[J]. Cell,2016, 166(6):1512-1525.e1512.
[10]Lee S H, Min K J. Caloric restriction and its mimetics[J]. BMB Rep, 2013, 46(4):181-187.
[11]Janakiram N B, Mohammed A, Madka V, et al. Prevention and treatment of cancers by immune modulating nutrients[J]. Mol Nutr Food Res, 2016, 60(6):1275-1294.
[12]Lamas B, Vergnaud-Gauduchon J, Goncalves-Mendes N, et al. Altered functions of natural killer cells in response to L-Arginine availability[J]. Cell Immunol, 2012, 280(2):182-190.
[13]Norian L A, Rodriguez P C, O′Mara L A, et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism[J]. Cancer Res, 2009, 69(7):3086-3094.
[14]Ochoa A C, Zea A H, Hernandez C, et al. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma[J]. Clin Cancer Res, 2007, 13(2 Pt 2):721s-726s.
[15]陈峰,郑晓红,李文斌.脑胶质瘤免疫治疗进展[J].首都医科大学学报,2019,40(6):966-971.
[16]黎可人,孙诚谊.肝癌的免疫治疗进展[J].中华肿瘤防治杂志,2018,25(17):1266-1270.
[17]Hansen A M, Caspi R R. Glutamate joins the ranks of immunomodulators[J]. Nat Med, 2010, 16(8):856-858.
[18]Fallarino F, Volpi C, Fazio F, et al. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation[J]. Nat Med, 2010, 16(8):897-902.
[19]Kuhn K S, Muscaritoli M, Wischmeyer P, et al. Glutamine as indispensable nutrient in oncology: experimental and clinical evidence[J]. Eur J Nutr, 2010, 49(4):197-210.
[20]Elinav E, Nowarski R, Thaiss C A, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms[J]. Nat Rev Cancer, 2013, 13(11):759-771.
[21]Facciabene A, Motz G T, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis[J]. Cancer Res, 2012, 72(2):2162-2171.
[22]Song M, Nishihara R, Cao Y, et al. Marine omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cells[J]. JAMA Oncol, 2016, 2(9):1197-1206.
[23]Manning J, Mitchell B, Appadurai D A, et al. Vitamin C promotes maturation of T-cells[J]. Antioxid Redox Signal, 2013, 19(17):2054-2067.
[24]Jubri Z, Latif A A, Top A G, et al. Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation[J]. Nutr J, 2013, 12:2.
[25]Song M, Chan A T. Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research[J]. Curr Colorectal Cancer Rep, 2017, 13(6):429-439.
[26]Zheng H, Zhao W, Yan C, et al. HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma[J]. Clin Cancer Res, 2016, 22(16):4119-4132.
[27]Song M, Chan A T. The potential role of exercise and nutrition in harnessing the immune system to improve colorectal cancer survival[J]. Gastroenterology, 2018, 155(3):596-600.
[28]Bonaventura P, Benedetti G, Albarede F, et al. Zinc and its role in immunity and inflammation[J]. Autoimmun Rev, 2015, 14(4):277-285.
[29]Li P, Xu J, Shi Y, et al. Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis[J]. Clin Nutr, 2014, 33(3):415-420.
[30]Tsuji P A, Carlson B A, Anderson C B, et al. Dietary selenium levels affect selenoprotein expression and support the interferon-gamma and IL-6 immune response pathways in mice[J]. Nutrients, 2015, 7(8):6529-6549.
[31]Wood S M, Beckham C, Yosioka A, et al. beta-Carotene and selenium supplementation enhances immune response in aged humans[J]. Integr Med, 2000, 2(2):85-92.
[32]Sivan A, Corrales L, Hubert N, et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J]. Science, 2015, 350(6264):1084-1089.
[33]Lopez P, Gueimonde M, Margolles A, et al. Distinct bifidobacterium strains drive different immune responses in vitro[J]. Int J Food Microbiol, 2010, 138(1-2):157-165.
[34]Hebert J R, Shivappa N, Wirth M D, et al. Perspective: the dietary inflammatory index (DII)-lessons learned, improvements made, and future directions[J]. Adv Nutr, 2019, 10:185-195.